A possible explanation for this effect is that SH3BP4 has the ability to regulate the activity of dynamin40, whereby it enables the processing of amyloid β protein precursors resulting in lower levels of Aβ depositions and AD pathology. Here, SH3BP4 is linked to Alzheimer disease.